Modeling and Simulation - PK/PD Archives | Page 8 of 46 | Certara

Guide

MBMA vs. Meta-Analysis: Quick Comparison Guide

Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…

CertaraOctober 8, 2025

On-Demand Webinar

Certara University: Introducing Certara’s Phoenix Cloud TFL Studio: Streamlined Creation of Tables, Figures & Listings

Watch Certara’s webinar with Kristin Follman to discover how TFL Studio streamlines the process to…

CertaraSeptember 22, 2025

Guide

Top 10 Things to Know About ADNCA for Non-Compartmental Analysis

Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…

CertaraSeptember 11, 2025

Blog Knowledge Base

What is a Loading Dose?

Learn what a loading dose is, why it's vital for reaching therapeutic drug levels swiftly,…

CertaraSeptember 10, 2025

Conference

The Pharmacometrics Africa Conference 2025 (PMXAC-2025)

CertaraSeptember 4, 2025

On-Demand Webinar

Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH)

Learn to design drug development programs for First-in-Human (FIH) success with biomarkers, PK/PD modeling, and…

CertaraAugust 29, 2025

Live Events

Phoenix Roadshow 2025 – Basel

CertaraAugust 29, 2025

Publication

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

CertaraAugust 13, 2025

Publication

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…

CertaraAugust 13, 2025

Blog

Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development

Learn how our experts use concentration-QTc (C-QTc) analysis to replace costly TQT studies, streamline QT…

CertaraAugust 6, 2025

© 2026 Certara. All Rights Reserved. | Legal | Privacy policy